-
Immunotherapy CombinationsResearchers are combining immunotherapies with each other and with other treatments in hopes that a larger proportion of patients will have long-term benefits.
by Kate Yandell
-
Forward Look
Inside InflammationQ&A with molecular biologist Michael Karin on inflammation and cancer.
by Robin Meadows
-
-
From the Editor-in-Chief
Palliative Care: Putting a Cloak on CancerPatients should have access to this vital and emerging medical specialty.
by William G. Nelson, MD, PhD
-
Forward Look
Making Treatment DecisionsPersonal goals come into play for patients with advanced cancer.
by Kendall K. Morgan
-
Forward Look
Advances in Treating Non–Small Cell Lung CancerExpanded approvals in 2016 increase options.
by Jennifer L.W. Fink
-
Forward Look
Cancer Cells Can Change as They Grow and SpreadStudies suggest metastases may respond to different drugs than the primary tumor.
by Chris Palmer
-
-
A Prescription for Prevention?Scientists are working to understand the molecular processes that transform normal cells into cancer cells in the hope they can prevent the disease before it starts.
by Marci A. Landsmann
-
Seeking a Second OpinionAnother perspective on your disease may help you find the best cancer care.
by Stephen Ornes
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
